Plain-English translation of NCT06344338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called transcranial direct current stimulation (tDCS) — a non-invasive technique that uses a small electrical current delivered through the scalp to help control severe seizures. The study focuses on people whose seizures have not stopped despite taking multiple seizure-fighting medications. Researchers want to see whether this treatment can help stop these hard-to-control seizures.
Some people's seizures do not respond to standard medications, which is a serious medical emergency called refractory status epilepticus. This trial exists because doctors need new treatment options for patients whose seizures continue despite current medicines, and this non-invasive brain stimulation approach may offer hope.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either real or sham (fake) brain stimulation sessions. The real treatment involves 20-minute sessions of electrical stimulation applied to your scalp, repeated twice per day over several days, for a maximum of 10 sessions total. The sham group receives the same setup and duration, but the device is not actually active. You will need to be monitored with an EEG during this time to track your brain activity and seizure control.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
China
Sponsor
Xuanwu Hospital, Beijing
Enrollment target
~32 participants
Started
April 2024
Primary completion
October 2026
Age range
14 Years – 80 Years
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
research centre of Xuanwu hospital Capital Medical University
Xuanwu Hospital, Beijing
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.